Antonio Blanca PérezCarmen Rueda Parras
This study was negative for the primary end point, but findings for the secondary end points suggest that sargramostim therapy decreased disease severity and improved the quality of life in patients with active Crohn's disease.
Carmen Sotelino PolonioEufemia Rosso Delgado
Josep Císcar VercherSara Fita EsteveOdiel Galán OlcinaXavier Fonfria de la Torre
Juan Carlos Tójar HurtadoAntonio Matas Terrón
Manuela Sanz ValenzuelaAntonio Pantoja Vallejo